Author: Mokhtar

  • August 2023 — Bone Talk

    August 2023 — Bone Talk

    shutterstock 1063113389

    As team captain of Be Bone Strong™, Barbara Hannah Grufferman, a nationally recognized positive living advocate, award-winning author and avid marathoner, will provide guidance and support to the team. To date, Barbara has run fourteen marathons and countless half marathons and other smaller races, all since she turned 50. She is passionate about motivating people to exercise more, and encourages everyone to focus on their bone health to age better. . Barbara also serves as a BHOF Trustee and Bone Health Ambassador.

    Jill Pompi has worked in public education for more than thirty years, teaching master’s degrees in education and consulting for school districts across the country. When Jill reached her forties, she began registering for local races. She ran many 5K, 10K and half marathons (both local and destination races) in her 40s, and when she turned 50 she set a goal of running a full marathon. Jill has run 8 marathons and is excited to be running the New York Marathon for the first time in November, and even more excited that she is running for a good cause!

    About steps for strong bones

    To keep you on track and motivated, BHOF hosts monthly Zoom meetings at noon ET on the first Monday of each month. This is an opportunity to connect with like-minded individuals and share your progress. You will also have the opportunity to listen to motivational speakers and talk about your experiences with motivating you to exercise. If you would like to participate (once or multiple times), click here to register and we will be sure to send you the link to the Zoom meeting every month. Join us when you can!

    NOTE: Due to Labor Day, the next Steps for Strong Bones program will take place on Monday, September 11 at noon ET.

    And if you are already motivated and moving forward on your own, consider becoming a member BHOF’s Be Bone Strong™ team to raise money to support their mission. It’s a great way to give back while doing activities you probably already enjoy in your area.

    Remember: stay strong and get enough weight-bearing exercise is crucial for the health of your bones. So commit to moving more this year and join us on our journey to Steps to Strong Bones™!

    Source link

  • What is a patient-reported outcome measure or PROM and the KOOS?

    What is a patient-reported outcome measure or PROM and the KOOS?

    Image by FatCamera from Canva Pro

    Are you recovering from a knee injury or knee surgery and are you asked to complete a questionnaire, the so-called Knee Injury and Osteoarthritis Outcome Score (KOOS)? This blog highlights the purpose of these questionnaires and explains what the KOOS is and how it is relevant to you and your recovery process. The first part discusses the purpose of these questionnaires in general and why you should care about them. The second part looks specifically at the KOOS and explains who it is designed for, what it measures, how it is scored, what it tells you about your knee and how it is relevant to you.

    Why should I give feedback and are there any benefits for me?

    Do you ever wonder why smartphones keep getting bigger or why your favorite website keeps changing its homepage? Well, it all comes from asking people what they want and then incorporating some or all of this feedback into the design of products and services.

    For example, if you use our Curovate app for your knee replacement, ACL injury, or surgery recovery or hip replacement recovery, you’ve probably seen this one!

    Curovate 1
    Curovate app review screenshots. Curovate is a physiotherapy app for knee replacement, ACL injury or surgery, knee osteoarthritis and video-guided hip replacement recovery.

    The purpose of this is to understand how you experience the app so we can make changes to improve your recovery at home after surgery and injury. You may think, “If the product works, I’ll be happy with the results,” or “giving feedback only helps the makers and doesn’t help me,” but that’s not the case. For example, a water bottle may be advertised as the perfect insulated bottle that can keep liquids cold for 42 hours. Even if you love the insulated feature of the bottle, you may not buy it because you simply hate the look or because the design of the bottle makes it impractical to carry around. By giving your feedback you not only help the creator of the product, but you also help create something for yourself.

    What is a patient reported outcome measure or PROM and why should I worry about it?

    The same concept of feedback is important in healthcare. For example, if you are a weightlifter recovering from ACL reconstruction surgery, there are a few important factors to consider as it relates to your recovery. First, you want to be sure that the surgery was successful in repairing your ACL. Secondly, as a weightlifter you also want to be sure that you can continue to lift heavy weights and do what you love.

    To measure both aspects and determine the effectiveness of the treatment, two different outcome measures are used. Objective physician-based outcome measures (CBOMs) typically include clinical data such as range of motion, knee laxity, or knee strength, which are objectively collected by your healthcare provider.[1] CBOMs can be useful in determining whether your ACL reconstruction surgery is successful from a clinical perspective.

    Patient-reported outcome measures (PROMs), on the other hand, allow you to report your symptoms, your level of disability, and your health-related quality of life, all from your perspective.[2] So PROMs can be used to let your doctor know about any limitations you may be experiencing that may be hindering your ability to lift weights. PROMs can also help you better understand whether you are making progress while recovering from injury or surgery.

    Although CBOMs are defined by a standardized outcome from a physician’s perspective,[3] PROMs are intended to help you achieve the outcome you want by allowing you to report symptoms that are most relevant to you and your lifestyle.[4]

    What exactly is the KOOS, who is it intended for and what does it require?

    Since different conditions require different treatments, there are therefore also specific outcome measures to assess a specific treatment. A reliable and valid PROM, specialized for people with various knee conditions, including ACL injuries, ACL surgery, meniscal injuries, focal cartilage lesions, knee osteoarthritis, knee replacement and various other knee conditions, is the Knee Injury and Osteoarthritis Outcome Score (KOOS). .[5][6] The KOOS is used by people in their twenties to people in their eighties.[6] The KOOS is a self-reported questionnaire that takes approximately 10 minutes to complete. You will be asked to complete the questionnaire once before the treatment or surgery begins, and again after the treatment or surgery has taken place.[5]

    In terms of questions, the KOOS assesses five of the following dimensions: pain (nine items); symptoms (seven items); activities of daily living (17 items); sports and recreational function (five items); and knee-related quality of life (four items).[5] For reference, here is an example of the entire KOOS questionnaire.[5]

    How is the KOOS scored?

    Each item on the KOOS is scored on a 5-point Likert scale, with 0 representing the least severe and 4 the most severe.[4] A 5-point Likert scale allows you to show how strongly you feel about a particular question and gives you five options from which to select the one that best represents how you feel.[7] An example question from the symptom dimension of the KOOS and the 5-point Likert scale can be found in the image below:

    Screenshot 110 1
    KOOS question #1 relates to a person’s symptoms. The Likert scale shown above provides options to rate your symptoms from ‘Never’ to ‘Always’.

    Each answer is associated with a score and each item score is then summed to give a total for that specific dimension. For example, the scores of all nine items from the pain dimension are summed to give a total score for pain. The total scores for each of the five dimensions are then converted to a scale of 0-100, with zero representing extreme knee problems and 100 no knee problems.[5]

    What does the KOOS tell me about my knee and why is this important for me and my recovery process?

    A KOOS is usually performed after an injury, after treatment, before surgery and after surgery. The KOOS can provide insight into the course of your knee injury or knee surgery and also allows healthcare providers to monitor the effect of the treatment over time.[8] It is important and necessary to have tests that can measure both short- and long-term outcomes, as traumatic knee injuries often result in damage to multiple structures such as ligaments, menisci, or cartilage.[8] and can ultimately lead to knee osteoarthritis, a degenerative joint disease characterized by pain, stiffness, swelling and limitations in joint function.[9] Given its ability to monitor both short- and long-term effects, the KOOS is therefore an effective tool to measure improvements or identify deterioration over time for people recovering from traumatic knee injuries.

    As a person who has had a knee injury or surgery, it is valuable to compare your own KOOS scores with other people who have had a similar injury or surgery. Doing this can help you determine your level of functioning, progress, and limitations at any given time compared to others who have undergone the same injury or surgery.[10] In part 2 of the KOOS blog we discuss normative values ​​for the KOOS and how to interpret these scores so you can compare your progress and understand what normal progress is.

    Conclusion

    A PROM is a patient-reported outcome measure. Typically, people complete these questionnaires after the injury, before surgery, after treatment, after surgery, and when they have completed treatment or rehabilitation. These questionnaires provide some insight into how the person is doing and can show progress or lack of progress. PROMs are important for you and your healthcare provider to better understand your current capabilities and limitations. One such PROM is called the Knee Injury and Osteoarthritis Outcome Score or KOOS. The KOOS asks various questions about pain (nine items); symptoms (seven items); activities of daily living (17 items); sports and recreational function (five items); and knee-related quality of life (four items). The KOOS only take 10 minutes and can provide a lot of insight into how your knee is doing. Read the blog above for more information about PROMs and the KOOS. Stay tuned for our second part of the KOOS blog, which will provide normal values ​​for various knee injuries and surgeries.

    If you have had a knee injury or surgery, try our Curovate app for your daily recovery. Curovate offers video-guided daily exercises, progress tracking, the ability to measure the range of motion of your knee and hip, and the ability to complete the KOOS outcome measurement, all within the app.

    If you need more tailored help during your surgery or recovery from your injury, check out our Virtual Physiotherapy page to book your 1-on-1 video session with a physiotherapist.

    acl knee physical therapy 1080x1080 2
    Download it on Google Play



    Document

    Other recommended blogs

    References


    Source link

  • COVID-19 increases the risk of autoimmune diseases

    COVID-19 increases the risk of autoimmune diseases

    From a recent study published in JAMA network openedresearchers analyzed the incidence and risk of autoinflammatory and autoimmune diseases following the coronavirus disease 2019 (COVID-19).

    ImageForNews 761174 16969009566415654 Study: Autoimmune and autoinflammatory connective tissue disorders after COVID-19. Image credits: Kateryna Kon / Shutterstock.com

    COVID-19 and autoimmunity

    The causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can trigger autoimmune reactions and, as a result, contribute to autoimmunity. In fact, several studies have described the development of vitiligo, alopecia areata, vasculitis, and systemic lupus erythematosus (SLE) after recovery from COVID-19.

    Respiratory and cardiovascular outcomes after COVID-19 have been extensively evaluated due to the potential role of SARS-CoV-2 in heart failure. Similarly, similarities have been reported between autoimmune diseases and COVID-19; However, autoimmune diseases have not been extensively investigated as post-acute consequences of COVID-19.

    About the study

    In the current study, researchers evaluate the risk and incidence of various autoinflammatory and autoimmune connective tissue disorders after recovery from COVID-19. To this end, data from the Korean COVID-19 National Health Insurance Service (NHIS) registry were collected for people with a COVID-19 diagnosis and general health assessment from October 8, 2020 to December 31, 2021.

    Individuals who underwent a general health examination and were not diagnosed with COVID-19 were identified as a control group. All study participants were followed until outcome diagnosis, death, emigration, or study end date. The risk and incidence of autoinflammatory and autoimmune diseases were estimated in study participants without these conditions before COVID-19.

    The occurrence of these disorders was defined as having three or more medical visits with associated clinical diagnosis codes. Cardiovascular outcomes reported to be associated with COVID-19 were positive control outcomes, while outcomes less likely to be associated with COVID-19 were negative control outcomes.

    Demographics, lifestyle factors, socio-economic status and comorbidity data were obtained from the NHIS database. Propensity scores and inverse probability weights were also estimated.

    Risk of outcomes was assessed for COVID-19 and control cohorts. A multivariable Cox proportional hazards analysis was performed, with adjustments for covariates. Subgroup analyzes were conducted based on gender, age, COVID-19 severity, and vaccination status.

    Findings of the study

    The study included 354,527 and 6.13 million individuals with and without COVID-19, respectively, with well-balanced covariates. The mean follow-up duration was 119.7 days for the COVID-19 cohort and 121.4 days for the control group.

    The COVID-19 cohort had a significantly higher risk of Crohn’s disease, sarcoidosis, alopecia areata, alopecia totalis and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, while the risk of SLE was lower.

    The overdetection bias was minimal in the COVID-19 cohort. Women in the COVID-19 cohort were at greater risk of subsequently developing vitiligo, Crohn’s disease, sarcoidosis, alopecia totalis, alopecia areata, and ANCA-associated vasculitis.

    By comparison, men in the COVID-19 cohort were at greater risk of developing ankylosing spondylitis, systemic sclerosis, adult-onset Still’s disease, Crohn’s disease, psoriasis and alopecia totalis. The risks of ANCA-associated vasculitis and alopecia totalis were much higher in those aged 40 years or older.

    The risks of sarcoidosis, adult-onset Still’s disease, rheumatoid arthritis and Crohn’s disease were also higher in people under 40. The overall risk of incidents increased as the severity of COVID-19 increases.

    Unvaccinated individuals were at greater risk of developing Crohn’s disease, alopecia totalis, alopecia areata, and positive control results. This additional risk of positive control results and autoimmune diseases was not identified in vaccinated individuals.

    In sensitivity analyses, the researchers compared demographic and clinical data between individuals with a general health examination and those without. The group studied consisted mainly of adults, as the health research focuses on workers and households. Both groups showed similar COVID-19 positivity rates; however, more examined individuals were vaccinated than unexamined individuals.

    Conclusions

    The current study compared the risks of autoinflammatory and autoimmune diseases in individuals with a history of COVID-19 versus non-COVID-19 controls. These risk estimates in the predominantly Asian sample were likely lower than in other ethnic groups, which may be due to delayed disease development/progression.

    Some limitations of the current study include the primarily adult population and the fact that the sample consisted entirely of Asians, limiting the generalizability of these findings to other ethnic groups and adolescents/children. In addition, the researchers were unable to determine whether some individuals were more susceptible to autoimmunity than others.

    Overall, the study’s findings suggest that SARS-CoV-2 infection may be associated with autoimmune diseases. Thus, long-term management of COVID-19 patients should also include autoimmunity assessments.

    Source link

  • Osteocytes: the ignored but crucial multitasking bone cells and how to activate them

    Osteocytes: the ignored but crucial multitasking bone cells and how to activate them

    For decades, scientific studies and writings on the cells that determine bone health have focused on two types of cells: osteoblasts and osteoclasts. But it turns out that a third type of cell, long overlooked and underestimated, could be the key regulator of bone remodeling.

    Today we will highlight this often overlooked bone cell. You’ll gain an in-depth understanding of how it manages the strength and quality of your bones, along with its surprising role in other body systems.

    Then we look at an overview of scientific studies that give you concrete steps to improve the bone-building ability of these powerful cells.

    A mystery of bone biology solved

    Osteocytes make up 90 to 95 percent of all bone cells, making them the most common type. Despite their ubiquity, they have received relatively little attention and scientific research compared to osteoclasts and osteoblasts.

    Osteoclasts are the cells responsible for reabsorbing old or damaged bone mass. Osteoblasts create and deposit new bone mass. These two easily observable actions have dominated the study of bone health and our understanding of the mechanisms of bone loss and osteoporosis.

    However, several questions remained unanswered. How do osteoblasts and osteoclasts communicate? How do they know how much bone to resorb or build? We can see that bone adapts to use, as stated in Wolff’s law: the more you use the muscles connected to a bone, the more mass that bone will add. But what do bones feel like when muscles are used?

    Over the past decade, the consensus among scientists has pointed to osteocytes as the answer to these questions.1,2

    Short content

    Osteocytes are the most common type of bone cell, but their function was unknown for decades. Meanwhile, questions remained about how the body regulates bone remodeling. Recent research suggests that osteoclasts are responsible for regulating the cells that carry out bone remodeling.

    Osteocytes are the center of bone regulation

    Until recently, scientists thought that osteocytes were just a passive placeholder in the structure of bone. Unlike short-lived osteoblasts and osteoclasts, osteocytes live for years or even decades.

    Osteocytes are distributed throughout the bone, in small cavities known as lacunae. They have tentacle-like dendrites that extend and connect to the surface of bones, other cells and even blood vessels.

    All these observable features turned out to be clues to the function of these cells. Due to their even distribution and interconnectedness, they are well positioned for their primary task: monitoring the condition of the bones and regulating bone formation locally and systemically.3

    The mechanisms by which osteocytes fulfill this task remained unnoticed for decades. However, research has now shown that osteocytes sense mechanical pressure on bones and receive hormonal messages about bone quality.1

    In response, osteocytes produce and release compounds that stimulate the development and function of osteoblasts, the cells that build new bone, and osteoclasts, the cells that resorb old or damaged bone.

    They can send these chemical signals directly to other cells, or release them into the extracellular fluid, causing the production and activation of osteoblasts and osteoclasts.

    They can even release compounds into the bloodstream to send instructions to distant organs.3 This multitude of functions is unusual for a single cell, which typically has a more limited range of actions. Osteocytes are truly unique and powerful cells.

    Short content

    Recently, osteocytes have been discovered to perform several important functions in bone and body systems. They monitor the condition of the bones and regulate bone formation by releasing compounds that stimulate the production and function of osteoblasts and osteoclasts, the cells responsible for creating and resorbing bone mass.

    Osteocytes collect information and provide instructions

    Osteocytes, distributed throughout mineralized bone, have the unique ability to sense mechanical pressure on bone, making them mechanosensitive. That pressure is usually the result of the force exerted on the bones by muscles.

    With every movement we make, the muscles must contract and pull on the bone. Osteocytes sense this mechanical load and respond by releasing compounds called paracrine factors. These factors activate the bone remodeling process, ultimately resulting in the addition of bone mass in locations where bones are in use.

    This is the mechanism behind Wolff’s law, which states that bones adapt to use by adding mass. This principle also explains why exercise is so important for building bones

    Osteocytes also respond to hormonal information from other bone cells about the condition of those cells, such as damage and cell death. Osteocytes use that information to direct the production of osteoclasts to remove damaged or dead bone cells, and osteoblasts to replace them with healthy new bone mass.

    In addition, osteocytes release compounds that instruct the kidneys on the release of phosphate. In this regard, they function as endocrine cells and produce factors that regulate phosphate transport.3 Phosphate is an important building block of the bone mineral matrix. It combines with calcium to form hydroxyapatite crystals that strengthen bone.

    Short content

    Osteocytes can sense mechanical pressure on bones and receive information from hormones about the condition of bone cells. They respond to this mechanical and hormonal information by releasing paracrine factors that generate and activate osteoblasts and osteoclasts. They also communicate with the kidneys to regulate the release of phosphate to be used for the production of new bone mineral matrix.

    How osteocytes regulate bone remodeling

    Osteocytes regulate the bone remodeling cycle through the release of many different factors and compounds. They contain:3

    Savers will likely recognize some of these factors. Several of these are targeted by anti-osteoporosis drugs that artificially intervene in the regulation of the bone remodeling process.

    For example, the osteoporosis drug Prolia (denosumab) works by mimicking osteoprotegerin to inhibit RANKL and ultimately render osteoclasts inactive. The drug Evenity (romosozumab) inhibits sclerostin, a substance that limits bone formation. By inhibiting sclerostin, Evenity changes the instructions of the osteocytes, leading to increased bone formation.

    However, these pharmaceutical interventions have many negative side effects and are only temporarily able to overpower the body’s natural bone remodeling system. At best, the result is a short period of denser but less healthy bones.

    As savers know, bone mineral density is not the only or even the most important measure of bone health and fracture risk.

    Short content

    Osteocytes generate the factors involved in bone formation and resorption. These same factors are mimicked by drugs that artificially intervene in the regulation of the bone remodeling process to increase bone mineral density.

    How to improve osteocyte function

    As we age, more osteocytes die than are produced, and the function of the osteocytes declines. This is an underlying cause of bone remodeling imbalances, leading to bone loss and osteoporosis.4

    However, research has shown that regular, strenuous physical activity has a strong positive effect on bone health through the activation of osteocytes.5 This activation of osteocytes is essential for their function, and we can activate it through exercise.

    Many studies have proven the positive end results of regular exercise, including increasing strength, building bone, and preventing falls.6 Now we understand more about how that cause and effect goes through osteocytes.

    Short content

    The number and function of osteocytes decreases with age, but research has shown that regular, strenuous physical activity activates osteocytes and has a positive impact on bone health.

    What this means for you

    Activate your osteocytes through consistent weight exercises. These powerful cells are responsible for receiving information about what your body needs. Exercise tells your osteocytes that you need strong and durable bones. Through SaveTrainer you have access to all the support you need to build your ideal training routine.

    The Save Institute has specially designed the SaveTrainer to adapt to your needs. Professional trainers will guide you through exercises and activities at your level, and a wide variety of disciplines and workouts are available, from yoga to strength training and meditation classes. Take advantage of what SaveTrainer has to offer today.

    Upcoming research could reveal even more fascinating information about the capabilities of osteocytes. As you continue to learn, you will continue to apply your new knowledge to live the healthiest and fullest life possible.

    References

    1 https://www.annualreviews.org/doi/full/10.1146/annurev-physiol-021119-034332

    2 https://rmdopen.bmj.com/content/1/Suppl_1/e000049

    3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366431/#:~:text=They%20produce%20the%20soluble%20factors,kidney%20to%20regulate%20phosphate%20transport

    4 https://www.nature.com/articles/s41419-020-03059-8

    5 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705732/

    6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812467/



    Source link

  • Few definitive CTE cases have been detected with and without history of brain injury and collision sports

    Few definitive CTE cases have been detected with and without history of brain injury and collision sports

    Chronic traumatic encephalopathy Neuropathological changes are uncommon in men who played amateur American football

    Iverson GL, Jamshidi P, Fisher-Hubbard AO, Deep-Soboslay A, Hyde TM, Kleinman JE, deJong JL, Shepherd CE, Hazrati LN, Castellani RJ. Anterior neurol. June 19, 2023; 14:1143882. doi:10.3389/fneur.2023.1143882. PMID: 37404944; PMCID: PMC10315537.

    Full text freely available

    Take home message

    Among the brain tissue of men over 50, none showed a definitive neuropathological change in chronic traumatic encephalopathy (CTE). However, three or more authors found that 5% of brains showed ‘signatures’ of neuropathological changes in CTE, arising from cases with and without a history of collision sports.

    Background

    Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease that cannot be diagnosed until death. An update was recently published on defining cases. Rather than a general absence or presence, screeners may note the level of components or “signatures” of neuropathic CTE change.

    Study aim

    The authors evaluated brain tissue from the Lieber Institute for Brain Development Tissue Bank to examine CTE neuropathological changes in relation to a history of American football youth participation and suicide as a mode of death.

    Methods

    The authors assessed 186 donated male brains in a tissue bank enriched with samples from people with neuropsychiatric problems and suicide (~66 years old; 58 participated in a contact sport, 67 died by suicide). Two authors screened the brains. Five authors then examined the selected brains for signs of CTE using the 2016 and 2021 consensus definitions. The authors also reviewed clinical documents and interviewed relatives to determine their medical, social, demographic, family and psychiatric history. In addition, they took into account their history of head/brain trauma/injury and their personal history of participation and concussions in sports.

    Results

    No brain definitively met the criteria for neuropathic CTE change based on the 2016 or 2021 definition. Furthermore, the five authors never unanimously agreed on a case with “hallmarks” of neuropathic changes in CTE. However, three or more authors found 10 cases (5.4%) with “features” of one or both definitions for neuropathic change in CTE.

    The authors found no differences between CTE neuropathic change and personal history of playing American football or contact sports (contact sports = 9%, no contact sports = 4%). Furthermore, there was no difference between CTE tissue samples with neuropathic change and samples with a history of brain injury (brain injury = 4%, no brain injury = 6%), mood disorder (mood disorder = 6%, no mood disorder = 6.0%). ), or manner of death (suicide = 6%, non-suicide = 5%).

    Viewpoints

    Overall, no definitive case of CTE was identified in this sample. Some authors found ‘signatures’ of neuropathic changes in CTE in 1 in 20 brains. Therefore, this condition was very uncommon in men who played amateur football, in people with mood disorders during life and in people with suicide as the cause of death. One of the notable strengths of this study was that the authors used a different brain bank, focusing around the brain tissue donations on psychiatric conditions and not on sports history. The findings at this bank were consistent with low rates at other banks, such as 4% of cases at the Military Brain Tissue Bank. However, these former banks do not represent the general population. It remains unclear how common CTE and “signatures” of neuropathic changes in CTE occur in the general population. This is essential to understand how prevalent CTE is in society and to accurately assess who is at risk for CTE and what the “signatures” of CTE are.

    Clinical implications

    Medical professionals can reassure people that, despite recent media attention, the prevalence of CTE and its characteristics are relatively small. That said, we need to point out to our stakeholders (e.g. parents, patients) that the level of evidence in this area is weak and there is much for us to learn. Doctors should promote positive brain health by limiting repetitive head impacts by improving rules and regulations in contact sports and limiting contact during exercises.

    Questions for discussion

    Do you believe that there would be an increased risk of CTE pathology in those who have played contact sports in the past or have a history of repetitive brain injury? How do you inform your patients about CTE?

    related posts

    1. Treatable conditions should be explored in former athletes with CTE-like symptoms
    2. CTE found in people with no history of contact sports
    3. When it comes to Chronic Traumatic Encephalopathy (CTE), Mom may not know best
    4. Can playing contact sports in high school and college increase the risk of CTE?
    5. Disconnect between concussion education and CTE
    6. Most military members don’t have to worry about CTE

    Written by Jane McDevitt
    Reviewed by Jeffrey Driban

    Evidence-based assessment of concussion course - 5 EBP CEUs

    Source link

  • Understanding osteoarthritis: symptoms, causes and treatment options

    Understanding osteoarthritis: symptoms, causes and treatment options

    A woman suffering from back and neck pain Osteoarthritis is painful for many people and affects their daily activities and quality of life. The progression of this degenerative joint disease can be slow and gradual, leading to discomfort and movement limitations. Despite its prevalence, there is still much to learn about osteoarthritis and how to treat it effectively.

    Our blog article explores the symptoms, causes and treatment options of osteoarthritis. Whether you’re just starting to experience symptoms or have been struggling for a while, there is hope for relief. So let’s take a look at this common form of arthritis.

    What is osteoarthritis?

    Osteoarthritis is a common form of arthritis that affects millions of people around the world. It is a degenerative joint disease that causes the cartilage in the joints to wear out, leading to pain, stiffness and movement problems. Although it can occur in any joint, it is most common in weight-bearing joints such as the hips, knees and spine.

    Symptoms of osteoarthritis

    The symptoms of osteoarthritis can vary from person to person, but common symptoms include joint pain, stiffness, swelling, and a grinding or grinding sensation when moving the affected joint. These symptoms may be mild at first and only occur during certain activities, but may worsen over time and become constant.

    Causes of osteoarthritis

    Several factors can increase the risk of developing osteoarthritis, including age, obesity, genetics, joint injury and overuse of the joint. As we age, the natural wear and tear on our joints can lead to osteoarthritis, and excess weight can put extra strain on the joints, leading to the development of the disease. Genetics may also play a role, as some people are prone to developing osteoarthritis.

    Treatment options for osteoarthritis

    Treatment for osteoarthritis depends on the severity of the disease, but several options are available to control symptoms and improve quality of life. These options include physical therapy, pain management, joint injections, and in some cases, surgery. It is critical to work with a healthcare provider to determine the best course of treatment for your specific situation.

    Schedule a consultation

    Do you have complaints of osteoarthritis and would you like to know more about your treatment options? Contact Bone and Joint Specialists in Indiana at 219-795-3360 to schedule a consultation today!

    Source link

  • 7 things I want my daughter to know within 24 hours of tearing an ACL

    7 things I want my daughter to know within 24 hours of tearing an ACL

    As my daughter continues to process the injury, I would do my best to gauge where she is mentally. Is she still focused on the injury itself, or has she opened a window to talk about the recovery process? If I feel like a window has opened to talk about the recovery process, here’s what I want her to know.

    5. Throughout your life you will realize that life is not about what happens to you, but about how you respond to it. This is one of those moments.

    6. Recovering from an ACL injury involves the same principles that made you such a great athlete. You will apply the same hard work, discipline, focus and mental strength to get back to full health.

    7. At some point you will decide whether or not you want to put the same energy you put into your sport into this recovery. If you choose, you can come back from this bigger, faster, stronger (and smarter, too).

    The more technical article will come at some point (I still have my list of 20+ items). For me at least, it is my natural instinct as a parent to help my daughter through difficult moments in life (in my case, at 19 months, it is telling my daughter: “It’s okay, no problem” right after she falls is ). I suppose this is why I moved so quickly to technical information in my first approach.

    But for now, in these first 1-7 days after my daughter was injured, I just want her to know that she is supported, and that ultimately it is her choice what perspective she has on the recovery process. Once she comes to the conclusion that she is ready to put her full mental and physical energy into the recovery process, the technical information awaits… and we get to work.



    Source link

  • THINK Surgical’s TMINI System Receives Special 510(k) Clearance from the FDA for Use with Complementary Implants

    THINK Surgical’s TMINI System Receives Special 510(k) Clearance from the FDA for Use with Complementary Implants

    FREMONT, Calif., Oct. 23, 2023 /PRNewswire/ — THINK Surgical, Inc., an innovator in orthopedic surgical robots, today announced that its TMINI™ Miniature Robotic System has received special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with implants from three additional implant manufacturers.

    The TMINI system includes a wireless robotic handpiece that helps surgeons perform total knee replacements and received its first 510(k) clearance from the U.S. FDA in April 2023 for use with an implant from a single implant manufacturer.

    THINK Surgical is committed to an open implant library. The addition of the Classic® Knee System (Total Joint Orthopedics Inc.), Balanced Knee System (BKS®) and BKS TriMax® Knee System (Ortho Development Corporation) and U2™ Knee (United Orthopedic Corporation) to THINK Surgical’s Implant Data Hub (ID-HUB), a proprietary database of implant modules for use with the TMINI System, opens access and choice to surgeons.

    “We are excited to expand the number of implant modules supported by the TMINI system, giving more customers and patients access to robot-assisted technology for knee replacement.” said Stuart Simpson, president and CEO of THINK Surgical. “We are currently working on adding more implant modules to the TMINI system to continue our mission of an open implant library.”

    About THINK Surgical, Inc.

    THINK Surgical, Inc. is a privately held, US-based technology innovator that develops and commercializes orthopedic robots. THINK Surgical robots are open platforms that support implant brands from multiple manufacturers, allowing the surgeon to determine the implant choice.

    THINK Surgical actively works with healthcare professionals around the world to refine our orthopedic products to improve the lives of people suffering from advanced joint conditions with accurate, precise and intelligent technology. Refer to the TMINI Miniature Robotic System Instructions for Use for a complete list of indications, contraindications, warnings and precautions. For additional product information, please visit www.thinksurgical.com.

    THINK Surgical and TMINI are trademarks of THINK Surgical, Inc.

    Media contacts:

    THINK surgical
    Nick Margree
    nmargree@thinksurgical.com

    SOURCE THINK Surgical, Inc.

    rt

    Source link

  • Understanding the genetics of rheumatoid arthritis and its implications

    Understanding the genetics of rheumatoid arthritis and its implications

    Introduction

    Rheumatoid arthritis (RA) is an autoimmune disease that affects millions of people worldwide. Although the exact cause of RA remains unknown, research has shown that the genetics of rheumatoid arthritis play an important role in its development. In this article, we will delve deeper into the genetics of RA, examining the key genetic markers associated with the disease and their implications.

    genetics of rheumatoid arthritis

    Genetic markers associated with RA

    HLA-DR4: Revealing the dominant gene

    The HLA-DR4 human leukocyte antigen gene stands out as the gene most closely linked to RA. Individuals who possess this gene are more predisposed to developing the disease and often experience more severe symptoms. The HLA-DR4 gene encodes proteins responsible for distinguishing between self and foreign cellular materials, including viral and bacterial proteins.

    STAT4: The immune system regulator

    Another important genetic marker associated with RA is STAT4. This gene plays a crucial role in regulating and activating the immune system. Abnormalities in STAT4 function have been observed in individuals with RA, underscoring its significance in disease development.

    TRAF1 and C5: key players in chronic inflammation

    The genes TRAF1 and C5 have been identified as major contributors to chronic inflammation, a feature characteristic of RA. These genes play a crucial role in initiating and perpetuating the inflammatory response that leads to joint damage in individuals with RA.

    PTPN22: Influencing the progression of RA

    PTPN22 is a gene that influences the progression and expression of RA. Although the precise mechanisms by which it affects the disease are not yet fully understood, researchers have identified its involvement. Further studies are underway to unravel the complexity of PTPN22’s role in the development of RA.

    The complexity of genetic heredity and RA

    Although some of the genetics of rheumatoid arthritis are known and the above genetic markers are strongly associated with RA, it is essential to note that not everyone who possesses these genes will develop the disease, and conversely, not all individuals with RA have these genetic possess markers. This complexity suggests that other genetic and environmental factors may also contribute to the development of RA.

    The need for further research

    Although significant progress has been made in identifying genetic markers associated with RA, there is still much to learn. Researchers have discovered more than 100 regions in the genome that are linked to the risk of developing RA in different ethnicities. To understand why some individuals with these genetic markers develop the disease while others require no further investigation.

    Conclusion

    Genetics undoubtedly plays a crucial role in the development of rheumatoid arthritis. The HLA-DR4 gene is emerging as the primary genetic marker associated with RA, alongside other notable genes such as STAT4, TRAF1, C5 and PTPN22. However, the complexity of genetic inheritance suggests that additional factors contribute to the development of this debilitating autoimmune disease. Continued research in this area will provide valuable insights into the underlying mechanisms of RA, ultimately leading to improved diagnostic tools and targeted therapies for those affected.

    Source link

  • Dr.  Brown’s crystal ball predictions for 2023

    Dr. Brown’s crystal ball predictions for 2023

    1. Muscle testing will become as important as bone density testing as doctors understand the intertwined aging loss of both bone and muscle.
    2. Everything is energy” will become a well-known concept and the popularity of energy medicines will increase enormously. You’ll see more homeopathy, acupuncture, Qi Gong, Reiki and many other treatments including Chakra balancing and even alignment of the invisible energy fields around the body.
    3. Researchers will discover how to turn sound into bone by identifying the vibrational frequency capable of converting stem cells into osteoblast bone-building cells.
    4. Globally, there will be a push for universal vitamin D testing as the world absorbs the lessons from the recent flu epidemic.
    5. Government subsidies to the fossil fuel industry will be converted into subsidies for local fruit and vegetable production programs.
    6. The limitations of bone density testing by the current DEXA X-Ray system will become increasingly apparent, fueling a search for better ways to assess bone strength.
      The use of the new Italian ultrasound device for testing bone fragility will gain popularity in Europe. However, in the US, the medical industry will not embrace radiation-free ultrasound examination of bone, but will promote bone examination with CAT scans, despite the radiation exposure.
    7. In the world of bone drug therapy, this is the abbreviation NNT (Number needed to address) will be the question you ask. By popular demand, the marketing of pharmaceutical products will have to make the NNT public, that is, they will have to report the number of people treated to obtain one positive result.
      For example, they will have to report that 21 high-risk women need to be treated with Prolia for 3 years to prevent 1 vertebral fracture, and that 230 high-risk women need to be treated for 3 years to prevent 1 hip fracture.
    8. Scientists will highlight the link between the dangerous acidification of our environment (oceans, rivers, soils and air) and the health-threatening acidification of the human body.
    9. Bone health will be seen as both an indicator and a predictor of overall body health.
    10. “May I become as smart as my body” will become the new mantra as science explains to the public the great intelligence within each of us.
    11. Measuring the pH of urine the first morning will become as common as brushing your teeth as it becomes known that this simple measurement can reveal whether you are getting enough minerals or not.

    The message Dr. Brown’s Crystal Ball Predictions for 2023 appeared first on Better Bones, Better Body.

    Source link